Foresite Capital Management Iv, LLC Arbutus Biopharma Corp Transaction History

Foresite Capital Management Iv, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.76 - $4.97 $9.2 Million - $16.6 Million	-3,332,616 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.75 - $6.2 $5.83 Million - $20.7 Million	3,332,616 New	3,332,616 $10.4 Million
Q1 2020 May 14, 2020	SELL	$1.01 - $3.42 $3.74 Million - $12.7 Million	-3,705,128 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.87 - $2.89 $3.22 Million - $10.7 Million	3,705,128 New	3,705,128 $10.3 Million
Q3 2019 Nov 13, 2019	SELL	$1.34 - $2.4 $814,922 - $1.46 Million	-608,151 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$1.46 - $4.44 $286,590 - $871,549	-196,295 Reduced 24.4%	608,151 $1.27 Million
Q1 2019 May 14, 2019	SELL	$3.41 - $4.57 $2.65 Million - $3.55 Million	-777,829 Reduced 49.16%	804,446 $2.88 Million
Q4 2018 Feb 13, 2019	SELL	$3.5 - $9.66 $3.83 Million - $10.6 Million	-1,094,550 Reduced 40.89%	1,582,275 $6.06 Million
Q3 2018 Nov 13, 2018	BUY	$7.85 - $12.35 $196,250 - $308,750	25,000 Added 0.94%	2,676,825 $25.3 Million
Q2 2018 Aug 14, 2018	BUY	$5.0 - $7.35 $5.83 Million - $8.57 Million	1,166,580 Added 78.54%	2,651,825 $19.4 Million
Q1 2018 May 15, 2018	BUY	$4.4 - $6.05 $5.87 Million - $8.07 Million	1,334,653 Added 886.27%	1,485,245 $7.43 Million
Q4 2017 Feb 13, 2018	BUY	$4.45 - $7.7 $670,134 - $1.16 Million	150,592	150,592 $760,000

155

99.5M

2.31M

525K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.